🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/06/2007 | 46,47 | 46,99 | 45,80 | 46,13 | -0,43% | 2,57% | 11.768.516 |
| 22/06/2007 | 46,68 | 47,14 | 46,05 | 46,33 | -1,52% | 2,33% | 15.201.240 |
| 21/06/2007 | 46,80 | 47,26 | 46,24 | 47,04 | +0,08% | 2,18% | 12.389.980 |
| 20/06/2007 | 47,71 | 47,80 | 46,96 | 47,00 | -2,11% | 1,76% | 14.710.776 |
| 19/06/2007 | 48,33 | 48,65 | 47,88 | 48,02 | -0,61% | 1,60% | 9.811.062 |
| 18/06/2007 | 48,57 | 48,66 | 47,99 | 48,31 | -0,20% | 1,39% | 7.820.595 |
| 15/06/2007 | 48,56 | 49,22 | 48,14 | 48,41 | +1,00% | 2,22% | 14.308.449 |
| 14/06/2007 | 48,33 | 48,33 | 47,81 | 47,93 | -0,87% | 1,09% | 10.972.979 |
| 13/06/2007 | 48,05 | 48,54 | 47,43 | 48,35 | +0,90% | 2,30% | 12.061.537 |
| 12/06/2007 | 48,35 | 48,71 | 47,91 | 47,92 | -1,63% | 1,66% | 11.830.767 |
| 11/06/2007 | 48,00 | 49,00 | 47,75 | 48,71 | +1,81% | 2,60% | 13.044.142 |
| 08/06/2007 | 48,00 | 48,18 | 47,36 | 47,84 | -0,40% | 1,71% | 11.885.473 |
| 07/06/2007 | 48,13 | 48,44 | 47,93 | 48,03 | -0,83% | 1,05% | 14.175.667 |
| 06/06/2007 | 48,66 | 48,96 | 48,32 | 48,44 | -1,32% | 1,31% | 12.255.102 |
| 05/06/2007 | 49,30 | 49,32 | 48,41 | 49,08 | -0,60% | 1,86% | 15.301.534 |
| 04/06/2007 | 49,67 | 49,67 | 49,04 | 49,38 | -0,75% | 1,27% | 15.318.826 |
| 01/06/2007 | 50,11 | 50,48 | 49,50 | 49,75 | -0,59% | 1,94% | 11.650.616 |
| 31/05/2007 | 50,21 | 50,74 | 50,05 | 50,05 | -0,49% | 1,39% | 11.751.958 |
| 30/05/2007 | 50,72 | 50,72 | 49,58 | 50,30 | -1,29% | 2,24% | 15.706.166 |
| 29/05/2007 | 51,36 | 51,54 | 50,57 | 50,95 | -0,56% | 1,88% | 10.423.513 |
| 25/05/2007 | 51,23 | 51,29 | 51,03 | 51,24 | -0,09% | 0,50% | 13.246.510 |
| 24/05/2007 | 51,43 | 52,09 | 50,79 | 51,29 | -1,10% | 2,52% | 10.597.271 |
| 23/05/2007 | 51,89 | 52,19 | 51,62 | 51,86 | +0,37% | 1,10% | 10.507.353 |
| 22/05/2007 | 51,62 | 52,61 | 51,53 | 51,67 | +0,67% | 2,11% | 15.245.256 |
| 21/05/2007 | 50,60 | 52,19 | 50,57 | 51,33 | +1,01% | 3,19% | 20.620.134 |
| 18/05/2007 | 50,15 | 50,81 | 49,86 | 50,81 | +1,51% | 1,90% | 14.401.092 |
| 17/05/2007 | 50,28 | 50,55 | 49,93 | 50,06 | -0,44% | 1,23% | 9.680.481 |
| 16/05/2007 | 50,57 | 50,57 | 49,76 | 50,28 | +0,13% | 1,60% | 11.380.127 |
| 15/05/2007 | 49,68 | 50,27 | 49,60 | 50,21 | +1,04% | 1,34% | 12.289.686 |
| 14/05/2007 | 49,62 | 50,21 | 49,49 | 49,69 | +0,15% | 1,44% | 8.657.947 |